Top Markets
#1 Akedo Akedo +93.47%
#2 TENDIES TENDIES +74.83%
#3 Threshold Network Threshold Network +44.30%
#4 Verus Coin Verus Coin +43.84%
#5 MultiversX MultiversX +35.66%
#6 Mubarak Mubarak +32.96%
#7 Cash Cat Cash Cat +24.19%
#8 Bitway Bitway +23.60%
#9 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#10 OSK OSK +16.18%
Coin of the day
Akedo Akedo
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Rankning i aktier #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Aktiekurs
$0.51647906
Marknadsvärde
$226.16M
Förändring (1 dag)
5.29%
Förändring (1 år)
66.66%
Land
IN
Handel Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategori

Healthcare
Vinst för Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Shukra Pharmaceuticals Limited är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Shukra Pharmaceuticals Limited från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$1.21B -
HK